Batlag, Rolito C.

HRN: 23-63-60  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2023
CEFTRIAXONE 1G (VIAL)
09/04/2023
09/10/2023
IV
2g
OD
Lacerated Wound, R Foot
Waiting Final Action 
09/04/2023
METRONIDAZOLE 500MG (TAB)
09/04/2023
09/10/2023
IV
500 Mg
Q6H
Tetanus Infection
Waiting Final Action 
09/08/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/08/2023
09/14/2023
IV
500mg
Q6
Tatnus Infection
Waiting Final Action 
09/13/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/13/2023
09/20/2023
IV
4.5g
Q8H
CAP MR
09/13/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
09/13/2023
09/14/2023
TOPICAL
25g
PRN
Wound Debridement
Waiting Final Action 
09/22/2023
CLOXACILLIN 500MG (CAP)
09/22/2023
10/22/2023
PO
500MG
Qid
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: